“DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS”, ijai, vol. 5, no. 09, pp. 221–223, Sep. 2025, Accessed: Sep. 17, 2025. [Online]. Available: https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299